China Universal Asset Management Company’s vTv Therapeutics VTVT Stock Holding History

China Universal Asset Management Company’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.1K	Buy	+2,500	New	+$86.7K	0.01%	422

Other funds holding VTVT

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

China Universal Asset Management Company's VTVT Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 2,500 shares worth $94.1K. The stake represents 0.01% of the portfolio and ranks #422 among its holdings.

11 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

China Universal Asset Management Company held 2,500 shares of vTv Therapeutics worth $94.1K as of Q2 2026.
vTv Therapeutics was a new China Universal Asset Management Company position in Q2 2026.
vTv Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #422 holding.
11 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.